Levels of expression of CD19 and CD20 in chronic B cell leukaemias

Journal of Clinical Pathology

Volumn 51, Issue 5, 1998, Pages 364-369

  Ginaldi, Lia ^b   De Martinis, Massimo ^b   Matutes, Estella ^a   Farahat, Nahla ^a   Morilla, Ricardo ^a   Catovsky, Daniel ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

B cell leukaemias; B lymphocytes; CD19 and CD 20 antigens; Quantitative flow cytometry

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN;

ANTIBODY COMBINING SITE; ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; B LYMPHOCYTE; BLOOD CELL; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HAIRY CELL LEUKEMIA; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA;

EID: 0031837813     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.51.5.364     Document Type: Article

References (26)

1. Matutes E, Owusu-Ankomah K, Morilla R, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994;8:1640 5.
2. Pombo de Oliveira MS, Jaffe ES, Catovsky D. Leukaemic phase of mantle-zone (intermediate) lymphoma. Its characterisation in 11 cases. J clin Pathol 1989;42: 962 72.
3. Peters RE, Janossy G, Ivory K, et al. Leukemia-associated changes identified by quantitative flow cytometry. III. B-cell gating in CD37/k/1 clonality test. Leukemia 1994;8: 1864 70.
4. Bikoue A, George F, Poncelet P, et al. Quantitative analysis of leukocyte membrane antigen expression: normal adult values. Cytometry 1996;26:1 37 47.
5. Rothe G, Schmit G, for the Working Group on Flow Cytometry and Image Analysis. Consensus protocol for the How cytometric immunophenotyping of hematopoietic malignancies. Leukemia 1996;10:877 95.
6. Ginaldi L, Matutes E, Farahat N, et al. Differential expression of CD3 and CD7 in T-cell malignancies. A quantitative study by flow cytometry. Br J Haematol 1996; 93:921 7.
7. Lavabre-Bertrand T, Janossy G, Ivory K, et al. Leukemia-associated changes identified by quantitative flow cytometry. I. CD10O expression. Cytometry 1994;18:209 17.
8. Farahat N, Lens D, Zomas A, et al. Quantitative flow cytometry can distinguish between normal and leukaemic B-cell precursors. Br J Haematol 1995;91:640 6.
9. Almasri NM, Duque RE, Iturraspe J, et al. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia. Am J Hematol 1992;40: 259-63.
10. Marti GE, Faguet G, Bertin P, et al. CD20 and CD5 expression in B-chronic lymphocytic leukemia. Ann N Y Acad Sci 1992;651:480-3.
11. Witzig TE, Li C-Y, Tefferi A, et al. Measurement of the intensity of cell surface antigen expression in B-cell chronic lymphocytic leukemia. Am J Clin Pathol 1994;101: 312-17.
12. Tefferi A, Bartholmai BJ, Witzig TE, et al. Heterogeneity and clinical relevance of the intensity of CD20 and immunoglobulin light-chain expression in B-cell chronic lymphocytic leukemia. Am J Clin pathol 1996;106:457 61.
13. Lavabre-Bertrand T, Janossy G, Exbrayat C, et al. Leukemia-associated changes identified by quantitative flow cytometry. II. CD5 over-expression and monitoring in B-CLL. Leukemia 1994;8:1557-63.
14. Cabezudo E, Matutes E, Ramrattan M, et al. Analysis of residual disease in chronic lymphocytic leukaemia by flow cytometry. Leukemia 1997;11: 1909-14.
15. Bennet JM, Catovsky D, Daniel MT, et al. The FrenchAmerican-British (FAB) Cooperative Group. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. J Clin Pathol 1989;42:567-84.
16. Ginaldi L, Farahat N, Matutes E, et al. Differential expression of T cell antigens in normal peripheral blood lymphocytes: a quantitative analysis by flow cytometry. J Clin Pathol 1996;49:539-44.
17. Lenkei R, Andersson B, Determination of the antibody binding capacity of lymphocyte membrane antigens by flow cytometry in 58 blood donors. J Immunol Methods 1995;183:267 77.
18. Sato S, Steeber DA, Tedder TF. CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc Natl Acad Sci 1995;92:11558-62.
19. Loken MR, Shah VO, Dattilio KL, et al. Flow cytometric analysis of human bone marrow. II. Normal B-lymphocyte development. Blood 1987;70:1316-24.
20. Scheurmann RH, Racila E. CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy. Leuk Lymphoma 1995;18:385-97.
21. Kanzaki M, Shibata H, Mogami H, et al. Expression of calcium-permeable cation channel CD20 accelerates progression through the G1 phase in Balb/c 3T3 cells. J Biol Chem 1995;270:13099-104.
22. Tedder TF, Boyd AW, Freedman AS, et al. The B cell surface molecule B1 is functionally linked with B cell activation and differentiation. J Immunol 1985;135:973 9.
23. Valentine MA, Keier KE, Rossie S, et al. Phosphorylation of the CD20 phosphoprotein in resting B lymphocytes: regulation by PKC. J Biol Chem 1989;264:11282-7.
24. Matutes E, Morilla R, Owusu-Ankomah K, et al, The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish from B-cell disorders with hairy or villous lymphocytes. Leuk Lymphoma 1994;14:57-61.
25. Robbins BA, Ellison DJ, Spinosa JC, et al. Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia. Blood 1993;82:1277-87.
26. Visser L, Poppema S. Induction of B-cell chronic lymphocytic leukaemia and hairy cell leukaemia like phenotypes by phorbol ester treatment of normal peripheral blood B-cells. Br J Haematol 1990;75:359-65.